For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

A Cornwall surfer who had a whole arm amputated after contracting a rare form of cancer, fears anyone who suffers from the condition in the future could be forced to travel hours and many miles out of ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

Akston's first Ambifect(R) immuno-enhancing protein enters clinical trial at Purdue University, with Dutch Shepherd Rocco as the first patient -- Akston has launched a clinical study at Purdue ...

Paytin Curranknebel first remembers hearing about cancer as a 4-year-old, driving in the car with her grandma.

Ewing sarcoma is one of the most common types of bone cancer found in children and teenagers. When the cancer spreads to ...

and colleagues examined this approach for young patients with primary multimetastatic bone Ewing sarcoma. Eleven patients received standard first-line treatment in parallel with pazopanib. The ...

Takara Bio Inc. (($JP:4974)) announced an update on their ongoing clinical study. Takara Bio Inc. has announced a new clinical study titled ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Inhibrx Biosciences shares jumped in premarket trading after the company reported positive trial results for its cancer drug ozekibart, including promising data from expanded use. Shares jumped 62% to ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...